Dong-A ST Co., Ltd.
Research Dong-A ST Co., Ltd. (170900.KS) on Bullrun: market cap KRW 337.84B, dividend yield 2.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker170900.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 337.84B
- Dividend yield2.0%
- Financial periodQ2 2026
- RevenueKRW 224.66B
- Net incomeKRW 2.73B
- Free cash flow-KRW 1.13B
- Gross margin43.2%
Valuation Snapshot
latest market cap is KRW 337.84B; dividend yield is 2.0%.
Peer valuation comparison
Latest dividend yield is 2.01% versus a Healthcare sector median of 2.4% (16.3% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 337.84B | n/a | 2.0% | 700 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 700 KRW, yield 2.0%.
About Dong-A ST Co., Ltd.
Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Clofazimine cap. for lepromatous leprosy; Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj. to treat non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin inj./PFS for ovarian hyperstimulation and anovulation;
ETFs that hold Dong-A ST Co., Ltd.
US-listed ETFs
Dong-A ST Co., Ltd. is held by 15 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard FTSE Developed Markets Index Fund ETF Shares (VEA) | <0.01% | 0.03% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| Vanguard FTSE Pacific Index Fund ETF Shares (VPL) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | <0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Dong-A ST Co., Ltd.'s market cap?
Dong-A ST Co., Ltd.'s market capitalization is KRW 337.84B.
Does Dong-A ST Co., Ltd. pay a dividend?
Dong-A ST Co., Ltd. has a dividend yield of 2.0%.
What does Dong-A ST Co., Ltd. do?
Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Clofazimine cap. for lepromatous leprosy; Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj.